Schrödinger, Inc. is a life sciences and materials science software company known for its physics-based computational platform used in drug discovery and molecular design. The company combines advanced molecular simulations with machine learning to help pharmaceutical, biotechnology, and industrial companies accelerate R&D. Schrödinger also pursues its own internal drug discovery programs, often in collaboration with partners.
Schrödinger integrates physics-based molecular modeling with machine learning to improve the accuracy and scalability of in silico drug and materials design. Its strategy focuses on embedding AI/ML into its core simulation workflows, offering cloud-based platforms to pharmaceutical and industrial customers, and leveraging the same technology stack in its own co-discovery and internal pipeline programs.